Ovarian cancer treatment: The end of empiricism? - Test2 - elhamkhani - TriplyDB

Ovarian cancer treatment: The end of empiricism?

Ovarian cancer treatment: The end of empiricism?

http://www.wikidata.org/entity/Q36554444

about

Paclitaxel targets VEGF-mediated angiogenesis in ovarian cancer treatment The Emerging Role of Tyrosine Kinase Inhibitors in Ovarian Cancer Treatment: A Systematic Review.Targeting CD146 in combination with vorinostat for the treatment of ovarian cancer cells.Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant High-Grade Serous ovarian cancer Efficacy of Postoperative Hormone Replacement Therapy on Prognosis of Patients with Serous Ovarian Carcinoma.NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo.Selenium-enriched polysaccharides from Pyracantha fortuneana (Se-PFPs) inhibit the growth and invasive potential of ovarian cancer cells through inhibiting β-catenin signaling.Ovarian cancer targeted hyaluronic acid-based nanoparticle system for paclitaxel delivery to overcome drug resistance.Deregulated miR-296/S100A4 axis promotes tumor invasion by inducing epithelial-mesenchymal transition in human ovarian cancer.A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer.

P2860

Q28073057-2B28BD24-5A47-4A53-9170-C0D50199A9E4 Q30248645-1A47BE2A-85C8-4CFF-B15F-4556348F27DD Q33598464-FB6A05D9-E241-4662-842B-03DA747230DC Q36904012-7C11ADB1-D703-4006-813E-4BF0A535D1C2 Q36971744-1A5878C7-CE83-4EB2-9430-C336F3440F1B Q37272785-FA958509-6984-4B93-A9F9-1DBDACFB19B5 Q37317553-1F62C4B8-5E43-48BB-8204-434514901C02 Q38822371-9CAAEFF6-1447-42AB-94CB-0160136BEA66 Q41125929-7D971513-7DAE-4045-86DC-E40BD082975B Q47861842-C9E6B071-377F-437D-A90C-69E0380AABE7

P2860

Ovarian cancer treatment: The end of empiricism?

http://www.wikidata.org/entity/Q36554444

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Ovarian cancer treatment: The end of empiricism?

@ast

Ovarian cancer treatment: The end of empiricism?

@en

type

label

Ovarian cancer treatment: The end of empiricism?

@ast

Ovarian cancer treatment: The end of empiricism?

@en

prefLabel

Ovarian cancer treatment: The end of empiricism?

@ast

Ovarian cancer treatment: The end of empiricism?

@en

P1433

Q36554444-F84FB987-B754-4818-9581-4E3D4A805383

P1476

Q36554444-2C97A68E-A1C2-4AEA-A2AE-BDB69EBD2C66

P2093

Q36554444-2BF2AB6F-2AC5-4642-968B-A28AB49DF873

Q36554444-7ED1E219-A07A-4845-9A65-1B4EFF55B006

Q36554444-869B4A76-31F4-4920-AA74-60A380330BDC

Q36554444-8F046DC9-D047-465B-875D-118767FCCD77

P275

Q36554444-D17F8A8D-E9A3-4AAC-9259-E60B8B45F238

P2860

Q36554444-01A334B2-F513-4B9E-9857-F64C617CC2D9

Q36554444-01E28EF2-5358-4734-8A88-04C83EAF7E07

Q36554444-0445DF09-2887-47E7-AA53-482749DE13E5

Q36554444-0B940F58-0DF5-43CD-AC97-3B50A8182126

Q36554444-0CFF043B-9F88-4286-88E3-FC331D320B55

Q36554444-0D41C5C2-DE92-44AF-9A40-F2815DC8A5C4

Q36554444-0F0C0A68-9F6E-4C56-8BB8-973F522DF78D

Q36554444-10D1DF5F-7625-4821-A994-E729F5A5B1A7

Q36554444-1155D163-5E3C-42CE-8956-2EE7B5D383FD

Q36554444-135C148D-B37A-48CF-9F74-7FCBA3E13BED

P304

Q36554444-3252234E-0D15-4211-951C-98EC97D28B33

P31

Q36554444-666535F3-221A-444C-990B-C39B5AE58109

Q36554444-9E70FFF0-364E-4787-AB7A-20F5C5C811AD

P356

Q36554444-0BDFCD2C-3AC4-4451-BC32-B42AA53A9F10

P407

Q36554444-AA7B88B9-6721-4F5E-9FA1-F866854A0B3A

P433

Q36554444-9A7C420A-97FF-44E9-B6F8-0E355BC81EF6

P478

Q36554444-39D9CD49-63AE-4917-8186-E0BB0F657C6E

P5008

Q36554444-6F22DED3-EED6-41EA-B7DE-BC1B34EDC1CA

P577

Q36554444-1A71075D-36E1-458D-A5C9-98818858DF1A

Q36554444-620D7E9B-D2AA-4D0D-BEAA-52A92A8935AB

P698

Q36554444-D0C5D75A-80EC-4C47-90E5-EDA6BA2316D0

P921

Q36554444-299F00BC-B525-4559-86BD-EA6A28984782

Q36554444-A43CADBB-5584-4B20-BDAE-F5E0A9BFB9AB

P932

Q36554444-02F54CB8-2E40-4B2F-974F-DDB720E5D978

P356

P1433

P1476

Ovarian cancer treatment: The end of empiricism?

@en

P2093

Amit M Oza

http://www.w3.org/2001/XMLSchema#string

Elise C Kohn

http://www.w3.org/2001/XMLSchema#string

Katherine Karakasis

http://www.w3.org/2001/XMLSchema#string

Stephanie Lheureux

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivatives

P2860

Maintenance chemotherapy for ovarian cancer

BRCAness: finding the Achilles heel in ovarian cancer

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

Revisiting the role of radiation treatment for non-serous subtypes of epithelial ovarian cancer

Better therapeutic trials in ovarian cancer.

Integrated genomic analyses of ovarian carcinoma

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup.

Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study.

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results.

P304

3203-3211

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.29481

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2015-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2015-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26096019

http://www.w3.org/2001/XMLSchema#string

P921

ovarian neoplasm

P932

4744728

http://www.w3.org/2001/XMLSchema#string